Credits Available: 4.50 AMA PRA Category 1 Credit

Description: This curriculum aims to evaluate the landscape of BC management, delving into the latest breakthroughs, therapies, and strategies that have transformed our approach to this complex and chronic condition. This curriculum is designed to offer you a thorough understanding of the wide range of treatment modalities available. From conventional methods to cutting-edge innovations, our goal is to equip you with the insights needed to make informed decisions for optimizing BC management, including use of ADCs, immunotherapy, PARP-inhibitors and a potential therapeutic algorithm for HER 2-low breast cancer.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MBBS, MD, Nurse Practitioner, Physician Assistant, Pharmacist
Target Specialties: Gynecologic Oncology, Oncology

Stefan Paepke

Technische Universität München
Leader Senology

What about me ? So, I'm very focused on breast cancer treatment since decades - means my first attending ASCO was 1997, means a lot of experience, a lot of "old" knowledge for a comparison with the very exciting development of new strategies over the past few years.
So, I'm happy to discuss perspectives from different countries and clinics.